The purpose of this clinical study is to collect and evaluate the data from eye scans using an investigational three-dimensional eye imaging photography device called the Nidek Optical Coherence Tomography (OCT) RS-3000. OCT stands for Optical Coherence Tomography, a technique that uses invisible wavelengths of light to make detailed images of the tissues at the back of the eye. These images provide information that physicians may use to help diagnose eye conditions and/or to monitor changes in the eye during treatment.
This is a prospective, open-labeled, multi-center clinical study. After qualifying examination of a subject, 3D retinal measurement in the proximity of the optic disc and the macula are carried out for eligible subjects with normal eyes using an investigational three-dimensional eye imaging photography device called the Nidek Optical Coherence Tomography (OCT) RS-3000. The primary objective of this clinical study is to develop age-specific normal ranges for the thickness of the retina and retinal nerve fiber layer (RNFL) etc. using the Nidek Optical Coherence Tomography (OCT) RS-3000 with normative database. The secondary objective is to evaluate any adverse events found during the clinical study.
Study Type
OBSERVATIONAL
Enrollment
279
UC San Diego, Hamilton Glaucoma Center, Department of Ophthalmology
La Jolla, California, United States
USC Eye Institute, Keck Medical Center of USC
Los Angeles, California, United States
UC Davis, Medical Center, Department of Ophthalmology & Vision Science
Sacramento, California, United States
Development of age-specific normal ranges for the thickness of the retina and retinal nerve fiber layer (RNFL) and Optic Disc Analysis
The primary objective of this clinical study is to develop age-specific normal ranges for the thickness of the retina and retinal nerve fiber layer (RNFL)and Optic Disc Analysis.
Time frame: Subjects will be followed for the duration of the procedure, up to one day.
Evaluation of adverse events found during the clinical study
The secondary objective is to evaluate any adverse events found during the clinical study.
Time frame: Subjects will be followed for the duration of the procedure, up to one day.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.